封面
市场调查报告书
商品编码
1692226

数位呼吸设备市场 - 全球产业规模、份额、趋势、机会和预测,按产品、适应症、配销通路、地区和竞争细分,2020-2030 年

Digital Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球数位呼吸设备市场价值为 432.1 亿美元,预计到 2030 年将达到 775.4 亿美元,复合年增长率为 10.21%。医疗保健产业正在经历数位转型,这种转型延伸到呼吸照护领域。数位呼吸设备正在彻底改变全球呼吸疾病的管理、诊断和治疗方式。这些创新设备提供即时监控、个人化治疗方案和改善患者治疗效果。慢性阻塞性肺病 (COPD)、气喘和睡眠呼吸中止症等呼吸系统疾病是全球健康问题。因此,迫切需要先进的呼吸照护解决方案来帮助更有效地管理和治疗这些疾病。

市场概况
预测期 2026-2030
2024 年市场规模 432.1 亿美元
2030 年市场规模 775.4 亿美元
2025-2030 年复合年增长率 10.21%
成长最快的领域 网路药局
最大的市场 北美洲

数位呼吸设备已经成为医疗保健产业的重大变革。这些设备将尖端技术与呼吸护理相结合,提供了许多益处。数位呼吸设备提供有关患者肺功能和呼吸模式的即时资料。这种持续的监测使医疗保健提供者能够做出明智的决定并根据需要调整治疗计划。借助资料分析和机器学习演算法,这些设备可以根据每位患者的独特需求量身定制治疗方案。这种个人化的方法提高了治疗效果和患者满意度。患者可以在家中使用数位呼吸设备,减少频繁就诊的需要。医疗专业人员可以远端监控患者病情进展,确保在病情恶化时儘早介入。许多数位呼吸设备都具有鼓励患者遵守治疗计划的功能。这些可能包括提醒、游戏化元素和教育资源。

主要市场驱动因素

呼吸系统疾病的增加推动了全球数位呼吸设备市场的发展

主要市场挑战

资料安全和隐私问题

主要市场趋势

技术进步

目录

第 1 章:产品概述

第 2 章:研究方法

第 3 章:执行摘要

第 4 章:顾客之声

第五章:全球数位呼吸设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品(智慧型吸入器和雾化器、感测器和应用程式、其他)
    • 依适应症分类(气喘、慢性阻塞性肺病、其他)
    • 按配销通路(医院药房、零售药房、网路药房)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第 6 章:北美数位呼吸设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 加拿大
    • 墨西哥

第 7 章:欧洲数位呼吸设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章:亚太地区数位呼吸设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章:南美洲数位呼吸设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章:中东和非洲数位呼吸设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章:全球数位呼吸设备市场:SWOT 分析

第 14 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章:竞争格局

  • COHERO Health Inc.
  • Cognita Labs llc
  • Adherium Limited
  • Amiko Digital Health Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3M Health Care Limited
  • AireHealth, Inc.

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 17473

Global Digital Respiratory Devices Market was valued at USD 43.21 Billion in 2024 and is expected to reach USD 77.54 Billion in the forecast period with a CAGR of 10.21% through 2030. The healthcare industry is undergoing a digital transformation, and this transformation extends to the field of respiratory care. Digital respiratory devices are revolutionizing the way respiratory conditions are managed, diagnosed, and treated worldwide. These innovative devices offer real-time monitoring, personalized treatment plans, and improved patient outcomes. Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are a global health concern. As a result, there is an urgent need for advanced respiratory care solutions that can help manage and treat these conditions more effectively.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 43.21 Billion
Market Size 2030USD 77.54 Billion
CAGR 2025-203010.21%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Digital respiratory devices have emerged as a game changer in the healthcare industry. These devices combine cutting-edge technology with respiratory care, offering numerous benefits. Digital respiratory devices provide real-time data on a patient's lung function and breathing patterns. This continuous monitoring allows healthcare providers to make informed decisions and adjust treatment plans as needed. With the help of data analytics and machine learning algorithms, these devices can tailor treatment plans to each patient's unique needs. This personalized approach enhances treatment effectiveness and patient satisfaction. Patients can use digital respiratory devices at home, reducing the need for frequent clinic visits. Healthcare professionals can remotely monitor patients' progress, ensuring early intervention in case of deterioration. Many digital respiratory devices come with features that encourage patient adherence to treatment plans. These may include reminders, gamification elements, and educational resources.

Key Market Drivers

Rising Respiratory Disorders is Driving the Global Digital Respiratory Devices Market

Respiratory disorders have been on the rise worldwide, affecting millions of people and posing a significant healthcare challenge. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea have become increasingly prevalent due to factors like air pollution, smoking, and lifestyle changes. In response to this growing health concern, the global digital respiratory devices market has emerged as a crucial player in managing and monitoring these conditions effectively.

Respiratory disorders encompass a wide range of conditions that affect the lungs and airways, making it difficult for individuals to breathe properly. These disorders include asthma, COPD, pneumonia, bronchitis, and sleep apnea, among others. According to the World Health Organization (WHO), respiratory diseases are the leading cause of death worldwide, accounting for 10% of all deaths. This alarming statistic highlights the urgent need for better management and monitoring of respiratory health.

Several factors contribute to the rising prevalence of respiratory disorders. Poor air quality caused by industrial emissions, vehicular pollution, and other environmental factors can trigger and exacerbate respiratory conditions. Tobacco use remains a significant risk factor for respiratory disorders, including lung cancer, COPD, and emphysema. As more people move to cities, exposure to indoor and outdoor air pollutants increases, potentially leading to respiratory health problems. Sedentary lifestyles and unhealthy dietary habits have contributed to the rise of obesity, which is linked to respiratory conditions such as sleep apnea.

Digital respiratory devices have emerged as a crucial tool in the management and monitoring of respiratory conditions. These devices leverage cutting-edge technology to provide patients and healthcare professionals with real-time data and insights, enabling better disease management and improved quality of life. Digital respiratory devices, such as smart inhalers and continuous positive airway pressure (CPAP) machines for sleep apnea, collect and transmit data to healthcare providers. This data helps healthcare professionals monitor patients' progress and make necessary adjustments to their treatment plans. Smart inhalers are equipped with sensors that track inhaler usage. They remind patients to take their medication and provide feedback on technique, improving adherence to treatment regimens. Patients can now be monitored remotely, reducing the need for frequent clinic visits. This is especially beneficial during pandemics and for patients in remote areas. Digital respiratory devices allow for more personalized treatment plans. Healthcare providers can tailor interventions based on an individual's specific needs and responses to therapy.

Recent data from the World Health Organization (WHO) underscores the severity of respiratory diseases globally. In 2021, chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide, resulting in approximately 3.5 million deaths, which accounts for about 5% of all global deaths. Additionally, air pollution remains a critical factor, with WHO reporting that almost the entire global population (99%) breathes air that exceeds WHO air quality limits, leading to significant health risks. These statistics highlight the pressing need for effective management and monitoring solutions, such as digital respiratory devices, to combat the escalating burden of respiratory disorders.

Key Market Challenges

Data Security and Privacy Concerns

Data security and privacy concerns present a significant challenge for the global digital respiratory devices market as these devices collect, store, and transmit sensitive patient health information. The integration of digital technologies, such as smart inhalers, connected nebulizers, and remote monitoring systems, relies on cloud-based platforms and mobile applications to facilitate real-time tracking and personalized treatment plans. Patients' medical histories, treatment adherence patterns, and respiratory health data are transmitted to healthcare providers, increasing the risk of cyber threats and data breaches. Unauthorized access to such data can compromise patient confidentiality, leading to potential misuse of personal health information by cybercriminals, insurance companies, or unauthorized third parties.

Regulatory frameworks, including the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe, impose strict guidelines on healthcare data security. Compliance with these regulations requires significant investments in encryption technologies, secure cloud storage solutions, and cybersecurity protocols. Many digital respiratory device manufacturers and healthcare providers face challenges in meeting these stringent standards while ensuring seamless data access for patients and clinicians. Any failure to comply with these regulations can result in legal penalties, reputational damage, and loss of consumer trust.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed a remarkable transformation in recent years, primarily due to advancements in technology. One such area where technology has made substantial strides is in respiratory care. Digital respiratory devices have emerged as game-changers in the field, significantly improving the management of respiratory conditions. As a result, the global digital respiratory devices market is experiencing rapid growth, driven by innovative technologies that enhance patient care and revolutionize the way respiratory diseases are managed.

Smart inhalers have gained prominence as a breakthrough technology for managing conditions like asthma and COPD. These inhalers are equipped with sensors that monitor medication usage and inhalation technique. Patients can receive real-time feedback and reminders through smartphone apps, ensuring they adhere to their treatment plans. Internet of Things (IoT) technology has enabled the development of remote monitoring devices. These devices can track a patient's vital signs, oxygen levels, and lung function from the comfort of their homes. Healthcare providers can remotely assess data, make necessary adjustments to treatment plans, and intervene promptly when needed, reducing hospital admissions and emergency room visits. The integration of telemedicine and telehealth platforms with digital respiratory devices has enabled virtual consultations and remote disease management. Patients can consult with healthcare professionals, receive prescriptions, and access educational resources without leaving their homes. AI-powered algorithms are being utilized to analyze vast datasets generated by digital respiratory devices. This technology can predict disease exacerbations, identify trends, and provide personalized treatment recommendations based on individual patient data. Interoperability between different digital respiratory devices and electronic health records (EHRs) streamlines the sharing of patient information among healthcare providers. This connectivity enhances care coordination and ensures a holistic approach to managing respiratory conditions.

Key Market Players

  • COHERO Health Inc.
  • Cognita Labs llc
  • Adherium Limited
  • Amiko Digital Health Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3M Health Care Limited
  • AireHealth, Inc.

Report Scope:

In this report, the Global Digital Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Respiratory Devices Market, By Product:

  • Smart Inhalers & Nebulizers
  • Sensors & Apps
  • Others

Digital Respiratory Devices Market, By Indication:

  • Asthma
  • COPD
  • Others

Digital Respiratory Devices Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Digital Respiratory Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Respiratory Devices Market.

Available Customizations:

Global Digital Respiratory Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Respiratory Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others)
    • 5.2.2. By Indication (Asthma, COPD, Others)
    • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Digital Respiratory Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Respiratory Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Digital Respiratory Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Digital Respiratory Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Distribution Channel

7. Europe Digital Respiratory Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Respiratory Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom Digital Respiratory Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Italy Digital Respiratory Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. France Digital Respiratory Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Digital Respiratory Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Digital Respiratory Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digital Respiratory Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Digital Respiratory Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Digital Respiratory Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Digital Respiratory Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Digital Respiratory Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Distribution Channel

9. South America Digital Respiratory Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digital Respiratory Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Digital Respiratory Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Digital Respiratory Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Digital Respiratory Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digital Respiratory Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Digital Respiratory Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Digital Respiratory Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Digital Respiratory Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COHERO Health Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cognita Labs llc
  • 15.3. Adherium Limited
  • 15.4. Amiko Digital Health Limited
  • 15.5. Teva Pharmaceuticals Industries Ltd.
  • 15.6. Propeller Health
  • 15.7. Novartis AG
  • 15.8. Pneuma Respiratory Inc.
  • 15.9. 3M Health Care Limited
  • 15.10. AireHealth, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer